ProfileGDS5678 / 1425438_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 17% 17% 17% 17% 16% 18% 17% 21% 17% 17% 17% 17% 17% 17% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4436317
GSM967853U87-EV human glioblastoma xenograft - Control 22.4177317
GSM967854U87-EV human glioblastoma xenograft - Control 32.414217
GSM967855U87-EV human glioblastoma xenograft - Control 42.3565617
GSM967856U87-EV human glioblastoma xenograft - Control 52.3554616
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.4882618
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4494417
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4885721
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.3841617
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4017517
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.4048617
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.3817617
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.4083317
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.4046517